Company intelligence

Infinimmune

Biotech

Recent changes

  1. Aug 11, 2026Raised $75M Series A MedCity News
  2. Aug 11, 2026New investor: Regeneron Ventures MedCity News
  3. Aug 11, 2026New investor: Civilization Ventures MedCity News
  4. Aug 11, 2026New investor: Pear VC MedCity News
  5. Aug 11, 2026Infinimmune Raises $75M for Human-Derived Antibody Drugs Pulse story

Funding History

1 event ยท sources dated per row
DateEventAmountValuationInvestorsSource
Aug 11, 2026Series A$75Mโ€”
Regeneron VenturesCivilization VenturesPear VCMerck Global Health Innovation FundEverbright Biofund
outlined = lead
Pulse story

Investors

Latest Pulse

  1. Infinimmune Raises $75M for Human-Derived Antibody DrugsInfinimmune raised a $75 million Series A co-led by Regeneron Ventures and Playground Global to advance two atopic dermatitis antibody candidates built from its human-derived Anthrobody platform.โ†’

Coverage Timeline

newest first
  1. FUNDINGInfinimmune Raises $75M for Human-Derived Antibody Drugsโ†’

All Coverage

Related Companies

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data ยท Suggest a correction